Trial Design: Overview of Study Designs
- 46 Downloads
Clinical trials are fundamentally the investigation of human subjects under experimental conditions. For these trials to be successful, they must be well planned in the design phase to evaluate the prespecified outcomes. Thus, it is imperative for the investigators to understand clinical trial design which follows a typical progression from preclinical studies in animals to phase I–IV trials as described in this chapter (Fig. 4.1).
- 12.Buzdar AU, Ibrahim NK, Francis D, et al. Significantly higher pathologic complete remission rate after Neoadjuvant therapy with Trastuzumab, paclitaxel, and Epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2–positive operable breast Cancer. J Clin Oncol. 2005;23(16):3676–85.CrossRefGoogle Scholar
- 13.Buzdar AU, Suman VJ, Meric-Bernstam F, et al. Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(13):1317–25.CrossRefGoogle Scholar
- 20.Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons oncology group Z0011 randomized trial. Ann Surg. 2010;252(3):426–32.PubMedPubMedCentralGoogle Scholar
- 24.Singh P, Scoggins M, Sahin AA, et al. Effectiveness and safety of Magseed-localization for excision of breast lesions: a prospective trial. Poster presented at: SSO 2019 annual cancer symposium, March 29, 2019; San Diego, CA.Google Scholar